This document outlines categories and treatment regimens for tuberculosis (TB). Category I includes new cases that are smear-positive or seriously ill, treated with 2 months of intensive drugs followed by 4 months of maintenance drugs. Category II includes relapse or treatment failure cases, treated with 2 months of drugs including streptomycin followed by 5 months of additional drugs. Category III includes new smear-negative cases, treated with 2 months of intensive drugs followed by 4 months of maintenance drugs.
This document outlines categories and treatment regimens for tuberculosis (TB). Category I includes new cases that are smear-positive or seriously ill, treated with 2 months of intensive drugs followed by 4 months of maintenance drugs. Category II includes relapse or treatment failure cases, treated with 2 months of drugs including streptomycin followed by 5 months of additional drugs. Category III includes new smear-negative cases, treated with 2 months of intensive drugs followed by 4 months of maintenance drugs.
Copyright:
Attribution Non-Commercial (BY-NC)
Available Formats
Download as DOCX, PDF, TXT or read online from Scribd
This document outlines categories and treatment regimens for tuberculosis (TB). Category I includes new cases that are smear-positive or seriously ill, treated with 2 months of intensive drugs followed by 4 months of maintenance drugs. Category II includes relapse or treatment failure cases, treated with 2 months of drugs including streptomycin followed by 5 months of additional drugs. Category III includes new smear-negative cases, treated with 2 months of intensive drugs followed by 4 months of maintenance drugs.
Copyright:
Attribution Non-Commercial (BY-NC)
Available Formats
Download as DOCX, PDF, TXT or read online from Scribd
New Case 1. Relapse New case 1. Smear (+) 2. Treatment Failure 1. Smear (-) with minimal 2. Seriously ill 3. Return after default parenchymal lesions as 2.1 Smear (-) w/ 4. Other assessed by TBDC extensive parenchymal lesions Treatment: Treatment: as assessed by TBDC 3. Extrapulmonary 2 months-FD-A+ Streptomycin 2 months-FD-A 750 mg IM OD Treatment: 4months-FD-B 1 month F-D-A 2 months – FD – A Sputum AFB follow up 2 months (Intensive) 5 months F-D-B + Ethambutol after or before the end of intensive Isoniazide, Rifampicin, Sputum AFB follow up Pyrazinamide, Ethambutol 3-5-8